These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1462 related items for PubMed ID: 7559897

  • 41. Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone.
    Luder AS, Holland FJ, Costigan DC, Jenner MR, Wielgosz G, Fazekas AT.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):966-72. PubMed ID: 6427266
    [Abstract] [Full Text] [Related]

  • 42. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR, Aceto T, Weber C, Pang S.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Insulin-like Growth Factor 1, but Not Insulin-Like Growth Factor-Binding Protein 3, Predicts Central Precocious Puberty in Girls 6-8 Years Old: A Retrospective Study.
    Escagedo PD, Deal CL, Dwyer AA, Hauschild M.
    Horm Res Paediatr; 2021 Apr; 94(1-2):44-51. PubMed ID: 34098553
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [Abstract] [Full Text] [Related]

  • 49. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM.
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.
    Oostdijk W, Hümmelink R, Odink RJ, Partsch CJ, Drop SL, Lorenzen F, Sippell WG, van der Velde EA, Schultheiss H.
    Eur J Pediatr; 1990 Feb; 149(5):308-13. PubMed ID: 2138079
    [Abstract] [Full Text] [Related]

  • 54. Abnormal sex chromosome constitution and longitudinal growth: serum levels of insulin-like growth factor (IGF)-I, IGF binding protein-3, luteinizing hormone, and testosterone in 109 males with 47,XXY, 47,XYY, or sex-determining region of the Y chromosome (SRY)-positive 46,XX karyotypes.
    Aksglaede L, Skakkebaek NE, Juul A.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):169-76. PubMed ID: 17940117
    [Abstract] [Full Text] [Related]

  • 55. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC, de Jong FH, Rose SR, Odink RJ, Bakker-van Waarde WM, Sulkers EJ, Hokken-Koelega AC.
    Horm Res; 2009 Jan; 71(5):260-7. PubMed ID: 19339790
    [Abstract] [Full Text] [Related]

  • 56. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
    Wide L, Albertsson-Wikland K, Phillips DJ.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):216-21. PubMed ID: 8550754
    [Abstract] [Full Text] [Related]

  • 57. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C, Leonhardt S, Seidel C, Luft H, Wuttke W, Jarry H.
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [Abstract] [Full Text] [Related]

  • 58. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM, Ramirez NR, Conte FA, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [Abstract] [Full Text] [Related]

  • 59. Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue.
    Oliveira SB, Donnadieu M, Chaussain JL.
    Horm Res; 1993 Oct; 39(1-2):42-6. PubMed ID: 8406338
    [Abstract] [Full Text] [Related]

  • 60. Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin).
    Bourguignon JP, Van Vliet G, Vandeweghe M, Malvaux P, Vanderschueren-Lodeweyckx M, Craen M, Du Caju MV, Ernould C.
    Eur J Pediatr; 1987 Nov; 146(6):555-60. PubMed ID: 3123239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 74.